Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 90 | 1 | 11 | 0 | €995.00 | €1,064.7 | 7.004% |
| Boston Scientific | 77 | 0 | 11 | 0 | €40.39 | €83.22 | 106.070% |
| UnitedHealth Group Inc. | 77 | 3 | 13 | 0 | €361.80 | €369.41 | 2.104% |
| Abbott Laboratories | 69 | 0 | 10 | 0 | €91.92 | €114.37 | 24.425% |
| Gilead Sciences Inc | 65 | 0 | 5 | 0 | €113.32 | €128.14 | 13.082% |
| Ionis Pharmaceuticals Inc. | 64 | 1 | 10 | 0 | €45.26 | €79.22 | 75.034% |
| Insmed Inc. | 63 | 1 | 4 | 0 | €87.50 | €173.11 | 97.845% |
| Neurocrine Bioscience | 62 | 0 | 10 | 0 | €145.00 | €157.11 | 8.349% |
| Insulet Corp. | 60 | 1 | 3 | 0 | €143.75 | €305.21 | 112.319% |
| Johnson & Johnson | 56 | 0 | 12 | 0 | €223.25 | €227.33 | 1.826% |
| Dexcom Inc. | 58 | 2 | 9 | 0 | €72.20 | €75.82 | 5.011% |
| HCA Holdings Inc. | 55 | 2 | 8 | 2 | €344.20 | €435.61 | 26.559% |
| Alnylam Pharmace. | 50 | 0 | 10 | 0 | €177.30 | €428.30 | 141.567% |
| Vertex Pharmaceuticals Inc. | 47 | 1 | 3 | 1 | €414.15 | €467.05 | 12.773% |
| Regeneron Pharmaceuticals Inc. | 46 | 0 | 7 | 0 | €660.00 | €721.37 | 9.299% |
| Tenet Healthcare | 44 | 0 | 12 | 0 | €220.00 | €217.45 | -1.159% |
| AbbVie Inc. | 43 | 0 | 10 | 0 | €218.30 | €228.85 | 4.834% |
| Biogen Inc. | 43 | 1 | 10 | 1 | €177.82 | €200.07 | 12.510% |
| Jazz Pharmaceuticals plc | 41 | 0 | 5 | 0 | €219.30 | €224.09 | 2.182% |
| Cytokinetics Inc. | 41 | 0 | 0 | 0 | €68.14 | €81.13 | 19.064% |
| Medtronic plc | 41 | 1 | 2 | 0 | €74.36 | €97.41 | 30.991% |
| Rhythm Pharmaceuticals | 36 | 1 | 2 | 0 | €91.50 | €116.89 | 27.747% |
| Amgen Inc. | 36 | 2 | 2 | 0 | €334.20 | €332.22 | -0.594% |
| Agilent Technologies Inc. | 33 | 0 | 0 | 0 | €118.25 | €137.44 | 16.228% |
| Cigna Corp. | 32 | 0 | 0 | 0 | €252.10 | €288.04 | 14.256% |